Critical shortage of research funding

Critical research funding shortage TLymphocyteImmune diseases affect a large proportion of the population (1 in 4), however they currently represent a relatively small proportion of research funding. Only around $1 in every $100 of research funding in Australia is spent on immune disease research.

Research needed into prevention

Research needed into prevention-anaphylaxisThere is a significant need for more research funding into the causes and prevention of immune diseases, as well as how best to manipulate the immune system to prevent, treat or cure them.

AIFA established by experts

Foundation established by expertsAIFA was established in 2013 by the Australasian Society of Clinical Immunology and Allergy (ASCIA) to address the shortage of research funding for immune diseases. ASCIA is the peak professional body of clinical immunology and allergy in Australasia.

Donations spent on research

Donations spent on researchTo ensure that all donations are directed to funding research, ASCIA supports the running costs of AIFA. Donations are held in separate bank accounts and are independently audited. Financial reporting is compliant with Australian accounting standards. All donations are tax deductible.

Patient focused research objectives

Patient focused research objectives: Peanut UrticariaFunds donated to AIFA can be directed to targeted areas of research, with objectives that are patient focused.

World leading Australasian research

World leading Australasian researchApplications for AIFA funding of research projects are advertised to the medical research community in Australia and New Zealand, which includes world leading researchers.

Expert grant selection panel

Expert grant selection panelpAIFA grant applications are reviewed by a grant selection panel, which comprises 7 experts with extensive and world leading clinical and research experience, to ensure a rigorous selection process.

Grant selection criteria

Grant selection criteria essentialResearch projects funded by AIFA will be selected on the basis of specific criteria: originality and scientific quality; significance of outcomes with potential to help patients; methodology, team quality and capability.

Ongoing grant follow up

Ongoing grant follow upAIFA is committed to ongoing follow up of all research projects funded by its grant program, to ensure transparency, appropriate use of funds and optimal clinical outcomes.

Collaborative research is important

Collaborative research is importantMedical research into immune diseases often requires a collaborative and multidisciplinary approach between Immunologists, other medical disciplines (e.g. Neuroimmunology) and other health professionals (e.g. Dietitians and Nurses). AIFA’s founding organisation, ASCIA, has a strong track record in promoting collaborations.

World Allergy Week

World Allergy Week 2018 logo 275x298World Allergy Week is a global campaign of the World Allergy Organisation (WAO) which aims to raise awareness of the impact of allergy in our communities. In 2018 the focus area was Atopic Dermatitis/Eczema: An Itch that Rashes 

AIFA supports World Allergy Week each year through the annual 'wear a spot of red' campaign. We ask our supporters to help raise awareness and funds to support research into allergy by wearing a spot of red or holding an event in their home, school or workplace.

Some fun activities have been developed that can be used in preschools, early childhood education/care centres, classrooms or even at home. These include a 'spot the difference' game and a colouring in activity. Please feel free to download and use these activities during World Allergy Week.

This event is an initiative of AIFA and ASCIA, a World Allergy Organisation Member Society. AIFAASCIA

'Wear a spot of red' for World Allergy Week 2018 was proudly supported by Sanofi. Sanofi is a global biopharmaceutical company focused on human health and dedicated to supporting people through their health challenges.

SANOFIGENZYME logo V CMJN

 

 

Content updated November 2018

©2018 Allergy and Immunology Foundation of Australasia